pythia-2024

2026 BIO Asia TAIWAN

Thu, 16 Jul 2026 02:05:21 GMT

Pythia Biotech Successfully Concludes Its Participation at BIO Asia–Taiwan 2026, Showcasing Innovations in Its Tumor Microenvironment-on-a-Chip Platform

Pythia Biotech successfully concluded its four-day exhibition at BIO Asia–Taiwan 2026, where the company showcased its proprietary Tumor Microenvironment-on-a-Chip (TME-Chip) platform and Microphysiological System (MPS) technology. During the exhibition, Pythia introduced the platform's core technologies and demonstrated its applications in cancer research, drug discovery, translational medicine, and precision oncology to biotechnology, pharmaceutical, healthcare, and academic professionals from around the world.

Throughout the event, the Pythia team engaged in productive discussions with research institutions, biotechnology and pharmaceutical companies, healthcare professionals, and industry partners from both Taiwan and overseas. The team shared the latest progress and application outcomes of the TME-Chip platform while exploring potential collaborations in tumor modeling, therapeutic efficacy evaluation, immuno-oncology, drug penetration studies, and treatment response prediction.

Participation in BIO Asia–Taiwan 2026 further strengthened Pythia Biotech's relationships with existing collaborators while establishing new connections with prospective customers and international partners. These interactions expanded the company's collaborative network across the Asia-Pacific region and global markets, further enhancing Pythia's international visibility in the fields of tumor microenvironment modeling and microphysiological systems.

During the four-day exhibition, Dr. Kien-Thiam Tan, Chief Executive Officer of Pythia Biotech, delivered two featured stage presentations highlighting the company's core technologies, the unique advantages of the TME-Chip platform, and its long-term vision. He also shared how human-relevant tumor microenvironment models can advance cancer research, drug development, and precision treatment decision-making. The presentations attracted strong interest from professionals across academia, industry, and the healthcare sector, generating active discussions and receiving highly positive feedback.

Pythia Biotech sincerely thanks all visitors, collaborators, and industry partners who visited the company's booth and shared valuable insights throughout the exhibition. Looking ahead, the company remains committed to advancing the validation, commercialization, and broader application of the TME-Chip platform. By providing robust, scalable, and human-relevant tumor models, Pythia aims to accelerate oncology drug development and facilitate the translation of precision medicine into clinical practice.

2026 亞洲生技大展 BIO Asia Taiwan

Thu, 16 Jul 2026 01:46:16 GMT

諭泰生技圓滿完成 2026 亞洲生技大展參展，展現腫瘤微環境晶片平台創新成果

諭泰生技(Pythia Biotech)於 2026 亞洲生技大展（BIO Asia -Taiwan 2026）圓滿完成為期四天的展出。本次展會中，諭泰生技展示自主開發的腫瘤微環境晶片（Tumor Microenvironment-Chip, TME-Chip）平台與微生理系統 (Microphysiological System, MPS)，向來自全球生技、製藥、醫療及學術領域的專業人士，介紹平台的核心技術特色，以及其在癌症研究、藥物開發、轉譯醫學與精準醫療領域的應用潛力。

展會期間，團隊與國內外研究機構、生技醫藥企業、醫療專業人士及產業夥伴進行深入交流，分享 TME-Chip 平台的最新研發進展與應用成果，並探討其於腫瘤模型建立、藥物療效評估、免疫腫瘤學、藥物滲透及治療反應預測等領域的合作機會。

透過此次參展，諭泰生技不僅進一步深化與既有合作夥伴的連結，也與多家潛在客戶及國際合作夥伴建立初步交流，持續拓展公司在亞太地區及全球市場的合作網絡，並提升諭泰生技在腫瘤微環境模型與微生理系統技術領域的國際能見度。

此外，展會四天期間，諭泰生技執行長陳健添於兩場舞台短講中，介紹公司的核心技術、TME-Chip 平台優勢及未來發展願景，並分享具人體相關性的腫瘤微環境模型如何應用於癌症研究、藥物開發及精準治療決策。短講吸引眾多產學研領域專業人士參與，現場交流熱烈，並獲得來自各界的正面回饋。

諭泰生技感謝所有於展會期間蒞臨展位、參與交流及給予寶貴建議的合作夥伴與來賓。未來，公司將持續推進 TME-Chip 平台的技術驗證、產品化與應用拓展，致力於提供更具人體相關性、穩定且可規模化的腫瘤研究工具，協助加速癌症藥物開發與精準醫療的臨床轉譯。

晶片上的腫瘤微環境：器官晶片在動物實驗替代與癌症藥物開發的應用工作坊

Tue, 19 May 2026 03:10:27 GMT

2025 金炬獎

Tue, 16 Dec 2025 09:16:14 GMT

媒體報導：

2025 醫療科技展

Sun, 07 Dec 2025 09:11:51 GMT

2025 Healthcare Expo Taiwan ( InnoZone )

Sun, 07 Dec 2025 09:11:49 GMT

2025 International Innovation Awards, IIA (Enterprise Asia)

Fri, 28 Nov 2025 10:28:28 GMT

2025 國際創新獎

Fri, 28 Nov 2025 10:00:13 GMT

媒體報導：

2025 Bio Asia

Tue, 15 Jul 2025 09:54:48 GMT

2025 亞洲生技大展 BIO Asia TAIWAN

Tue, 15 Jul 2025 09:45:02 GMT

2025-先進醫療科技產品法遵研討會

Fri, 11 Jul 2025 09:38:03 GMT

很榮幸受邀參與「先進醫療科技產品法遵研討會」，由諭泰生技研究員鄭景家博士擔任講師，與業界先進分享諭泰生技在器官晶片產業的發展經驗。

2025-創業小聚

Mon, 12 May 2025 09:18:38 GMT

新藥不靠動物實驗？台灣新創諭泰用「器官晶片」改寫藥物測試方式

創業小聚媒體採訪連結

2024 21ᵗʰ National Innovation Award -Startups(Biopharmaceuticals and Precision Medicine)

Fri, 27 Dec 2024 09:34:52 GMT

2024第二十一屆國家新創獎初創企業獎

Fri, 27 Dec 2024 02:00:54 GMT

2024 經貿透視雙周刊第649期

Mon, 05 Aug 2024 07:38:53 GMT

領精準醫療新方向器官晶片技術備受矚目新創公司諭泰生技積極布局

在全球精準醫療發展中，器官晶片技術備受關注。臺灣新創公司諭泰生技在微流體晶片上培養細胞，模擬人體器官，可用於藥物篩選和毒性測試，比動物實驗更接近人體，提高新藥開發效率。

在全球精準醫療蓬勃發展的趨勢下，器官晶片（organ-on-a-chip）技術正成為備受矚目的新星。臺灣新創公司諭泰生物技術股份有限公司（Pythia Biotech）以其獨特的器官晶片技術，正積極布局這個充滿潛力的領域。

採訪連結

2024 亞洲生技大展 BIO Asia TAIWAN

Thu, 25 Jul 2024 09:39:22 GMT

BIO Asia TAIWAN

Wed, 24 Jul 2024 07:09:00 GMT

2024 北美生技展 US Bio

Sat, 01 Jun 2024 09:41:21 GMT

2024 US Bio

Sat, 01 Jun 2024 04:31:27 GMT

《清大、北醫聯手出擊替身醫療諭泰生技獲國際大廠默克合作仿生肺癌晶片蓄勢待發》環球生技月刊2024 Vol115 p76-77

Tue, 30 Apr 2024 12:59:01 GMT

《諭泰生技肺癌仿生晶片量產加速實現個人化醫療》環球生技月刊2024 Vol113 p33

Tue, 30 Apr 2024 12:55:47 GMT

Global Bio Monthly 2024 Vol115 p76-77

Wed, 31 Jan 2024 04:29:14 GMT

Global Bio Monthly 2024 Vol113 p33

Wed, 31 Jan 2024 04:28:31 GMT

2023 20ᵗʰ National Innovation Award - Precision Health(Biotech & New Drug Development)- THREE-DIMENSIONAL CELL CULTURING AND DRUG TESTING ANDSCREENING.

Fri, 22 Dec 2023 04:18:11 GMT

2023第二十屆國家新創精進獎

Wed, 20 Dec 2023 09:43:28 GMT

2023-默默輕鬆聊

Thu, 24 Aug 2023 10:54:53 GMT

採訪連結

2023-Podcast interview "Merck Life Science Taiwan"

Thu, 24 Aug 2023 04:24:51 GMT

默克簽訂合作備忘錄

Fri, 09 Jun 2023 10:56:58 GMT

Signed a memorandum of cooperation with Merck

Fri, 09 Jun 2023 04:26:17 GMT

2023 英國科技大展CogX Festival

Thu, 27 Apr 2023 13:08:59 GMT

2023 CogX Festival

Thu, 27 Apr 2023 04:16:34 GMT

2022 19ᵗʰ National Innovation Award - Precision Health(Biotech & New Drug Development)- THREE-DIMENSIONAL CELL CULTURING AND DRUG TESTING AND SCREENING.

Fri, 23 Dec 2022 06:04:28 GMT

2022 第十九屆國家新創精進獎

Thu, 22 Dec 2022 10:40:27 GMT

2022 德國醫材展Dusseldorf Medica Healthcare Innovation World Cup Top 12 Start-ups

Mon, 14 Nov 2022 10:40:31 GMT

2022 Dusseldorf Medica Healthcare Innovation World Cup Top 12 Start-ups

Mon, 14 Nov 2022 04:12:38 GMT

2022 百靈佳殷格翰生醫新創獨角獸 “Grass Roots” 支持計畫

Tue, 04 Oct 2022 10:41:26 GMT

2022 Boehringer Ingelheim “Grass Roots” Support Program

Tue, 04 Oct 2022 04:15:10 GMT

2021 TIE FUTURE TECH AWARD

Wed, 22 Dec 2021 04:11:04 GMT

2021 科技部未來科技獎

Tue, 21 Dec 2021 10:44:44 GMT

健保未來式-創辦人李岡遠醫師、劉承賢教授訪談

Fri, 08 Oct 2021 12:48:20 GMT

Interview with founders Dr. Li Gang Yuan and Professor Liu Cheng Xian

Fri, 08 Oct 2021 04:20:21 GMT